The occurrence of Raynaud's phenomenon in a general population: the Framingham Study.
The prevalence and predisposing conditions for primary and secondary Raynaud's phenomenon (RP) were examined in The Framingham Study based on 16 years of follow-up of a cohort of 4182 men and women. The association with atypical chest pain and migraine headache was also investigated. Over the 16 years of follow-up there were 130 men and 171 women who developed primary RP. The prevalence in women (9.6%) was somewhat higher than in men (8.1%) and 81.4% of the RP was primary. Secondary RP was equally prevalent in men (18.6%) and women (19.7%). The most common causes of secondary RP were beta-blocker use (34.2%), carpal tunnel syndrome (10.5%) and rheumatoid arthritis (7.2%). Primary RP cases differed from noncases by having lower systolic blood pressure (p < or = 0.001) and diastolic blood pressure (p < 0.0001), and more coronary disease (p = 0.009), smoking (p < or = 0.01) and higher blood sugars (p < or = 0.009). Atypical chest pain was present more often than noted previously in The Framingham Study general population survey, and was equally prevalent in primary and secondary RP and in the two sexes. Associated migraine was more prevalent in women (14.4%) than men (5.0%). Vibrating tool use with associated RP occurred in 14.6%.
Brand
F N
FN
Framingham Heart Study, Section of Preventative Medicine and Epidemiology, Boston University, School of Medicine, MA 01702, USA.
Larson
M G
MG
Kannel
W B
WB
McGuirk
J M
JM
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000150:complications; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure; D002349:Carpal Tunnel Syndrome / Q000150:complications; D015331:Cohort Studies; D003327:Coronary Disease / Q000150:complications; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008404:Massachusetts / Q000453:epidemiology; D008875:Middle Aged; D011928:Raynaud Disease / Q000453:epidemiology* / Q000209:etiology; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D014732:Vibration / Q000009:adverse effects
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose